3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Myelodysplastic Syndromes
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Hematologic Neoplasms
3
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Graft vs Host Disease
2
Ganglioneuroblastoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Teratoma
1
Recurrence
1
Neuroblastoma
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
High Risk Myeloid Malignancies
1
GATA2 Deficiency
1
Choriocarcinoma
1
Carcinoma, Embryonal
1
Interventions
Cyclophosphamide
9
X-Rays
8
Specimen Handling
8
Phantoms, Imaging
7
fludarabine
6
Magnetic Resonance Spectroscopy
6
cabozantinib
5
Gemcitabine
5
Biopsy
5
Nuclear Medicine Department, Hospital
4
Methotrexate
4
Doxorubicin
4
fludarabine phosphate
3
Ifosfamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
olaparib
2
mifamurtide
2
larotrectinib
2
ivosidenib
2
irinotecan sucrosofate
2
ensartinib
2
atezolizumab
2
Vincristine
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Thiotepa
×
90 days
×
Clear all
No trials found.